Related references
Note: Only part of the references are listed.Breast cancer subtyping from plasma proteins
Fan Zhang et al.
BMC MEDICAL GENOMICS (2013)
Is phosphoproteomics ready for clinical research?
Anton B. Iliuk et al.
CLINICA CHIMICA ACTA (2013)
Insulin-like factor binding protein-3 promotes the G1 cell cycle arrest in several cancer cell lines
Chen Wu et al.
GENE (2013)
The Oncogene HER2/neu (ERBB2) Requires the Hypoxia-inducible Factor HIF-1 for Mammary Tumor Growth and Anoikis Resistance
Kelly A. Whelan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Vimentin as a poor prognostic factor for triple-negative breast cancer
Nami Yamashita et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Pitfalls in outcome prediction of breast cancer
Emad A. Rakha
JOURNAL OF CLINICAL PATHOLOGY (2013)
Unconventional Secretion is a Major Contributor of Cancer Cell Line Secretomes
Laura Villarreal et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways
Matthew J. Rardin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes
B. Dutta et al.
BRITISH JOURNAL OF CANCER (2012)
Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping
Julia D. Wulfkuhle et al.
CLINICAL CANCER RESEARCH (2012)
Serum cytokeratin 19 fragments: a dedifferentiation marker in advanced thyroid cancer
Luca Giovanella et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
CD44+/CD24-/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome
Michael O. Idowu et al.
HUMAN PATHOLOGY (2012)
The mTOR Signalling Pathway in Human Cancer
Helena Populo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
C-terminal Modification of Osteopontin Inhibits Interaction with the αVβ3-Integrin
Brian Christensen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Keratin 8 phosphorylation regulates keratin reorganization and migration of epithelial tumor cells
Tobias Busch et al.
JOURNAL OF CELL SCIENCE (2012)
IGFBP5 induces cell adhesion, increases cell survival and inhibits cell migration in MCF-7 human breast cancer cells
Angara Sureshbabu et al.
JOURNAL OF CELL SCIENCE (2012)
Lectin Chromatography/Mass Spectrometry Discovery Workflow Identifies Putative Biomarkers of Aggressive Breast Cancers
Penelope M. Drake et al.
JOURNAL OF PROTEOME RESEARCH (2012)
A Strategy for Large-Scale Phosphoproteomics and SRM-Based Validation of Human Breast Cancer Tissue Samples
Ryohei Narumi et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Platform-independent and Label-free Quantitation of Proteomic Data Using MS1 Extracted Ion Chromatograms in Skyline APPLICATION TO PROTEIN ACETYLATION AND PHOSPHORYLATION
Birgit Schilling et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Evolution and roles of stanniocalcin
B. H. Y. Yeung et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Proliferation and tissue remodeling in cancer: the hallmarks revisited
E. K. Markert et al.
CELL DEATH & DISEASE (2012)
Functional roles and clinical values of insulin-like growth factor-binding protein-5 in different types of cancers
Gokce Gullu et al.
CHINESE JOURNAL OF CANCER (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Osteopontin: a potentially important therapeutic target in cancer
Mansoor Ahmed et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation
Jose T. Thaiparambil et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Secretome Compartment Is a Valuable Source of Biomarkers for Cancer-Relevant Pathways
Dario Caccia et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Understanding the Dual Nature of CD44 in Breast Cancer Progression
Jeanne M. V. Louderbough et al.
MOLECULAR CANCER RESEARCH (2011)
Characterization of Phosphoproteins in Gastric Cancer Secretome
Guang-Rong Yan et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2011)
Targeting the Phosphatidylinositol 3-Kinase Signaling Pathway in Breast Cancer
Leonel F. Hernandez-Aya et al.
ONCOLOGIST (2011)
Loss of Keratin 8 Phosphorylation Leads to Increased Tumor Progression and Correlates with Clinico-Pathological Parameters of OSCC Patients
Hunain Alam et al.
PLOS ONE (2011)
Conditioned media from cell lines: A complementary model to clinical specimens for the discovery of disease-specific biomarkers
Paul Dowling et al.
PROTEOMICS (2011)
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
Brendan MacLean et al.
BIOINFORMATICS (2010)
Osteopontin: An Effector and an Effect of Tumor Metastasis
L. A. Shevde et al.
CURRENT MOLECULAR MEDICINE (2010)
Characterization of the Human Plasma Phosphoproteome Using Linear Ion Trap Mass Spectrometry and Multiple Search Engines
Montserrat Carrascal et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Do serum biomarkers really measure breast cancer?
Jonathan L. Jesneck et al.
BMC CANCER (2009)
Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion
Alaa Afify et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Characterization of the Expression of Variant and Standard CD44 in Prostate Cancer Cells: Identification of the Possible Molecular Mechanism of CD44/MMP9 Complex Formation on the Cell Surface
B. Desai et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
An Initial Characterization of the Serum Phosphoproteome
Weidong Zhou et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery
Jessica Kao et al.
PLOS ONE (2009)
Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors
Thomas Frogne et al.
BREAST CANCER RESEARCH (2009)
High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance
Glen L. Hortin et al.
CLINICAL CHEMISTRY (2008)
The cancer secretome: a reservoir of biomarkers
Hua Xue et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Hydrophilic interaction chromatography reduces the complexity of the phosphoproteome and improves global phosphopeptide isolation and detection
Dean E. McNulty et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Mining the plasma proteome for cancer biomarkers
Samir M. Hanash et al.
NATURE (2008)
Cytokeratin fragments in the serum: Their utility for the management of oral cancer
Sharada S. Sawant et al.
ORAL ONCOLOGY (2008)
Tyrosine1248-phosphorylated HER2 expression and HER2 gene amplification in female invasive ductal carcinomas
Kiyomi Taniyama et al.
BREAST CANCER (2008)
Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution
Hasmik Keshishian et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Proteomics analysis of conditioned media from three breast cancer cell lines
Vathany Kulasingam et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
The paragon algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra
Ignat V. Shilov et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Silencing of FLRG, an antagonist of activin, inhibits human breast tumor cell growth
Diane Razanajaona et al.
CANCER RESEARCH (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
A probability-based approach for high-throughput protein phosphorylation analysis and site localization
Sean A. Beausoleil et al.
NATURE BIOTECHNOLOGY (2006)
Absolute quantification of multisite phosphorylation by selective reaction monitoring mass spectrometry - Determination of inhibitory phosphorylation status of cyclin-dependent kinases
Viveka Mayya et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms
Therese Sorlie et al.
BMC GENOMICS (2006)
Serum tumor markers in breast cancer: Are they of clinical value?
MJ Duffy
CLINICAL CHEMISTRY (2006)
Share Paper
